AIC
LIVE

Serial Number

79430127

Owner

AiCuris Anti-infective Cures AG

Attorney

Adam D. Mandell

Filing Date

Jul 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AIC Trademark

Serial Number: 79430127

AIC is a trademark filed by AiCuris Anti-infective Cures AG on July 10, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

AiCuris Anti-infective Cures AG (3 trademarks)

Friedrich-Ebert-Strasse 475

Entity Type: 99

Trademark Details

Filing Date

July 10, 2025

Registration Date

Not Registered

Published for Opposition

June 16, 2026

Goods & Services

Development of pharmaceutical preparations and medicines; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals; laboratory research in the field of pharmaceuticals; providing information technology services for the pharmaceutical and healthcare industries; providing medical research information in the field of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; conducting scientific research in the nature of clinical trials for pharmaceutical products for others; biological research, clinical surgery research and medical research; medical research laboratory services; scientific investigations for medical purposes

Medical services; pharmaceutical compounding services; medical screening; medical diagnostic services; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to medical products

Pharmaceuticals in the nature of pharmaceutical preparations for the treatment of viral infections; diagnostic preparations and materials, for medical and veterinary purposes; antibiotics; antifungal medication; anti-viral agents; anti-cancer drugs; immunomodulators being pharmaceutical preparations for stimulating or suppressing the human immune system; cellular function activating agents for medical purposes;; blood substitutes for medical purposes; blood protein fractions for medical purposes; enzyme preparations for veterinary purposes; enzymes for veterinary purposes; enzyme preparations for medical purposes; greases for medical or veterinary purposes; vaccines; stem cells for veterinary purposes; stem cells for medical purposes; blood plasma

Training services in the field of pharmaceutical and medical research and development; arranging and conducting of seminars in the field of pharmaceutical and medical research; teaching in the field of pharmacology; courses being training relating to science; publication of scientific information journals; non downloadable electronic publication in the nature of articles, brochures, abstracts and presentation slides in the field of pharmaceutical and medical research

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 27, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2026 TROA
REFUSAL PROCESSED BY IB
Jan 22, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 7, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 7, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 29, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 14, 2025 REPR